Global Spinal Muscular Atrophy Treatment Market Analysis, Trends, Size & Forecast to 2025 - ResearchAndMarkets.com

DUBLIN--()--The "Spinal Muscular Atrophy Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global spinal muscular atrophy treatment market to grow with a CAGR of 12.9% over the forecast period from 2019-2025.

The report on the global spinal muscular atrophy treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025. The study on spinal muscular atrophy treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on spinal muscular atrophy treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global spinal muscular atrophy treatment market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global spinal muscular atrophy treatment market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Growing awareness regarding SMA and its treatment
  • Rise in the government initiatives to improve healthcare infrastructure
  • Increasing R&D activities to develop novel treatments

2) Restraints

  • High cost of treatment
  • Lack of skilled professionals

3) Opportunities

  • More efficient products in pipeline

Company Profiles

  • Biogen Inc.
  • Cytokinetics Inc.
  • Novartis International AG
  • Ionis Pharmaceuticals Inc.
  • Isis Pharmaceuticals Inc.
  • F. Hoffmann-La Roche AG
  • Pfizer Inc.
  • PTC Therapeutics

What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the spinal muscular atrophy treatment market.

2. Complete coverage of all the segments in the spinal muscular atrophy treatment market to analyze the trends, developments in the global market and forecast of market size up to 2025.

3. Comprehensive analysis of the companies operating in the global spinal muscular atrophy treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Key Topics Covered

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

2.1. Spinal Muscular Atrophy Treatment Market Highlights

2.2. Spinal Muscular Atrophy Treatment Market Projection

2.3. Spinal Muscular Atrophy Treatment Market Regional Highlights

3. Global Spinal Muscular Atrophy Treatment Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter's Five Forces Analysis

3.4. Growth Matrix Analysis

3.4.1. Growth Matrix Analysis by Type

3.4.2. Growth Matrix Analysis by Treatment

3.4.3. Growth Matrix Analysis by Route of Administration

3.4.4. Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Spinal Muscular Atrophy Treatment Market

4. Spinal Muscular Atrophy Treatment Market Macro Indicator Analysis

5. Global Spinal Muscular Atrophy Treatment Market by Type

5.1. Type 1

5.2. Type 2

5.3. Type 3

5.4. Type 4

6. Global Spinal Muscular Atrophy Treatment Market by Treatment

6.1. Gene Replacement Therapy

6.2. Drug Therapy

7. Global Spinal Muscular Atrophy Treatment Market by Route of Administration

7.1. Oral

7.2. Intrathecal

8. Global Spinal Muscular Atrophy Treatment Market by Region 2019-2025

8.1. North America

8.1.1. North America Spinal Muscular Atrophy Treatment Market by Type

8.1.2. North America Spinal Muscular Atrophy Treatment Market by Treatment

8.1.3. North America Spinal Muscular Atrophy Treatment Market by Route of Administration

8.1.4. North America Spinal Muscular Atrophy Treatment Market by Country

8.2. Europe

8.3. Asia-Pacific

8.4. RoW

9. Company Profiles and Competitive Landscape

9.1. Competitive Landscape in the Global Spinal Muscular Atrophy Treatment Market

9.2. Companies Profiled

For more information about this report visit https://www.researchandmarkets.com/r/34jj15

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900